| COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic’s impact in type 1 and type 2 diabetes JM Gregory, JC Slaughter, SH Duffus, TJ Smith, LM LeStourgeon, ... Diabetes care 44 (2), 526-532, 2021 | 274 | 2021 |
| Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence DJ Moore, JM Gregory, YA Kumah-Crystal, JH Simmons Vascular health and risk management, 1015-1031, 2009 | 102 | 2009 |
| Type 1 diabetes mellitus JM Gregory, DJ Moore, JH Simmons Pediatrics in review 34 (5), 203-215, 2013 | 89 | 2013 |
| Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes … MJ Haller, SA Long, JL Blanchfield, DA Schatz, JS Skyler, JP Krischer, ... Diabetes 68 (6), 1267-1276, 2019 | 86 | 2019 |
| Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using … SH Duffus, ZA Ta'ani, JC Slaughter, KD Niswender, JM Gregory Diabetes, Obesity and Metabolism 22 (4), 688-693, 2020 | 51 | 2020 |
| The peripheral peril: injected insulin induces insulin insensitivity in type 1 diabetes JM Gregory, AD Cherrington, DJ Moore Diabetes 69 (5), 837-847, 2020 | 47 | 2020 |
| Insulin delivery into the peripheral circulation: a key contributor to hypoglycemia in type 1 diabetes JM Gregory, G Kraft, MF Scott, DW Neal, B Farmer, MS Smith, JR Hastings, ... Diabetes 64 (10), 3439-3451, 2015 | 47 | 2015 |
| Iatrogenic hyperinsulinemia, not hyperglycemia, drives insulin resistance in type 1 diabetes as revealed by comparison with GCK-MODY (MODY2) JM Gregory, TJ Smith, JC Slaughter, HR Mason, CC Hughey, MS Smith, ... Diabetes 68 (8), 1565-1576, 2019 | 41 | 2019 |
| Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis JJ Winnick, G Kraft, JM Gregory, DS Edgerton, P Williams, IA Hajizadeh, ... The Journal of clinical investigation 126 (6), 2236-2248, 2016 | 38 | 2016 |
| Aerobic exercise training improves hepatic and muscle insulin sensitivity, but reduces splanchnic glucose uptake in obese humans with type 2 diabetes JM Gregory, JA Muldowney, BG Engelhardt, R Tyree, P Marks-Shulman, ... Nutrition & diabetes 9 (1), 25, 2019 | 35 | 2019 |
| Fibrotic encapsulation is the dominant source of continuous glucose monitor delays PM McClatchey, ES McClain, IM Williams, CM Malabanan, FD James, ... Diabetes 68 (10), 1892-1901, 2019 | 31 | 2019 |
| Medical and psychological considerations for carbohydrate-restricted diets in youth with type 1 diabetes KAS Gallagher, D DeSalvo, J Gregory, ME Hilliard Current Diabetes Reports 19, 1-8, 2019 | 22 | 2019 |
| Intraperitoneal drain placement and outcomes after elective colorectal surgery: international matched, prospective, cohort study British Journal of Surgery 109 (6), 520-529, 2022 | 19 | 2022 |
| Importance of the route of insulin delivery to its control of glucose metabolism DS Edgerton, MC Moore, JM Gregory, G Kraft, AD Cherrington American Journal of Physiology-Endocrinology and Metabolism 320 (5), E891-E897, 2021 | 18 | 2021 |
| A new animal model of insulin-glucose dynamics in the intraperitoneal space enhances closed-loop control performance A Chakrabarty, JM Gregory, LM Moore, PE Williams, B Farmer, ... Journal of process control 76, 62-73, 2019 | 18 | 2019 |
| The dual burden of type 1 diabetes and COVID-19 JM Gregory, DJ Moore Annals of internal medicine 174 (5), 703-704, 2021 | 13 | 2021 |
| Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs JM Gregory, M Lautz, LM Moore, PE Williams, P Reddy, AD Cherrington Diabetes, Obesity and Metabolism 21 (1), 160-169, 2019 | 13 | 2019 |
| Incorporating type 1 diabetes prevention into clinical practice JM Gregory, JS Lilley, AA Misfeldt, DL Buscariollo, WE Russell, DJ Moore Clinical Diabetes 28 (2), 61-70, 2010 | 11 | 2010 |
| Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs JM Gregory, G Kraft, MF Scott, DW Neal, B Farmer, MS Smith, JR Hastings, ... Diabetes, Obesity and Metabolism 21 (10), 2294-2304, 2019 | 9 | 2019 |
| SGLT2 inhibition increases fasting glucagon but does not restore the counterregulatory hormone response to hypoglycemia in participants with type 1 diabetes SC Boeder, JM Gregory, ER Giovannetti, JH Pettus Diabetes 71 (3), 511-519, 2022 | 8 | 2022 |
